WELL Health USA Successfully Refinances $300M Credit Facility with JPMorgan Chase Bank

WELL Health USA Successfully Refinances $300M Credit Facility with JPMorgan Chase Bank

February 1, 2024 : WELL Health USA, a subsidiary of WELL Health Technologies Corp., has secured a significant financial advantage by successfully refinancing its US $300 million credit facility. Led by JPMorgan Chase Bank, N.A., this renewed agreement not only solidifies WELL Health USA’s financial stability but also unlocks substantial room for future growth.

The newly structured facility retains a primary credit line of $175 million and an additional $125 million accordion for strategic expansion. Notably, the refinancing terms remain unchanged from the previous agreement, reflecting strong financial performance and continued confidence from lenders. This stability signifies WELL Health USA’s commitment to prudent financial management while positioning the company for future success.

This strategic move provides several key benefits for WELL Health USA:

  • Enhanced Financial Flexibility: The increased credit line and accordion offer additional resources to pursue strategic investments, acquisitions, and organic growth initiatives, fueling the company’s expansion plans.
  • Competitive Advantage: Favorable borrowing terms strengthen WELL Health USA’s financial position, enabling it to compete effectively in a dynamic healthcare landscape.
  • Investor Confidence: The successful refinancing reinforces investor confidence in WELL Health USA’s long-term financial health and commitment to sustainable growth.

Jay Kreger, CEO of WELL Health USA, emphasizes the significance of this achievement: “This refinancing is a testament to the strength, resilience, and growth prospects of our business. This arrangement enhances our financial flexibility, essential for executing our strategic growth plans and maintaining our commitment to financial discipline.”

This financial milestone underscores WELL Health USA’s ongoing commitment to empowering healthcare practitioners and delivering positive health outcomes. By leveraging this strategic refinancing, the company can capitalize on future opportunities and solidify itself as a leading player in the evolving healthcare landscape.


Also Read, Accompany Health Launches with $56M Funding from Venrock and ARCH